Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Mouse (Murine) Thrombopoietin Primary Antibody for ELISA - ABIN411356
Bartley, Bogenberger, Hunt, Li, Lu, Martin, Chang, Samal, Nichol, Swift: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. in Cell 1994
Show all 2 references for ABIN411356
Human Thrombopoietin Primary Antibody for ELISA - ABIN625104
Yilmaz, Basar, Altınbas, Ekiz, Aktas, Oztürk, Ginis, Coban, Ucar, Erarslan, Coskun, Yüksel, Tuna, Yüksel: The utility of thrombopoietin in predicting liver fibrosis in chronic hepatitis B. in International journal of clinical and experimental medicine 2014
These studies indicate that the functional role of Tpo in the differentiation of thrombocytes from hematopoietic stem and progenitor cells is well conserved among vertebrate organisms, positing the zebrafish as an excellent model to investigate diseases caused by dysregulated erythro- and thrombo-poietic differentiation.
bone marrow megakaryocytes possess a complete mechanism to synthesize the ECM (show MMRN1 ELISA Kits) components, and that thrombopoietin is a pivotal regulator of this new function inducing transforming growth factor-b1 (TGF-beta1 (show TGFB1 ELISA Kits)) release and consequent activation of the downstream pathways, both in vitro and in vivo
High Thrombopoietin expression is associated with immune thrombocytopenia in pregnancy.
Colorectal cancer tumor-initiating cells (TICs) expressing CD110 (show MPL ELISA Kits), the thrombopoietin (TPO)-binding receptor, mediate liver metastasis. We show that TPO promotes metastasis of CD110 (show MPL ELISA Kits)+ TICs to the liver by activating lysine degradation.
decreased TPO levels or decreased bone marrow production of platelets may not be a cause of thrombocytopenia in chronic hepatitis C
WASP (show WASL ELISA Kits), RUNX1 (show RUNX1 ELISA Kits), and ANKRD26 (show ANKRD26 ELISA Kits) genes are important for normal TPO signaling and the network underlying thrombopoiesis.
Data suggest that elevated serum level of thrombopoietin may serve as unfavorable marker of stage of multiple myeloma.
The regulation of OCs by TPO highlights a novel therapeutic target for bone loss diseases and may be important to consider in the numerous hematologic disorders associated with alterations in TPO/c-mpl (show MPL ELISA Kits) signaling
TPO was greatly enhanced in HPT in comparison with ITP (show ITPA ELISA Kits) patients (958 +/- 659 and 11 +/- 27 pg/ml, p < 0.001). In the ITP (show ITPA ELISA Kits) group a reverse correlation was detected between TPO and glycocalicin (r = -0.373, p = 0.006).
observations suggest that NRP-1 (show NELL1 ELISA Kits) is involved in megakaryocytopoiesis through complex formation with PDGFRs, and that NRP-1 (show NELL1 ELISA Kits)-PDGFR (show PDGFRB ELISA Kits)-complexes may contribute to effective cellular functions mediated by TPO and PDGF (show PDGFA ELISA Kits) in megakaryocytic cells
Endocytic AMR (show GPR182 ELISA Kits) controls TPO expression through Janus kinase 2 (JAK2 (show JAK2 ELISA Kits)) and the acute phase response signal transducer and activator of transcription 3 (STAT3 (show STAT3 ELISA Kits)) in vivo and in vitro
The results demonstrate the possible involvement of locally produced TPO (show TPO ELISA Kits)/c-MPL (show MPL ELISA Kits) system as a 'physiological filter' in bovine ovary where they may promote cell selection by inducing proliferation of viable cells and scavenging non-viable cells.
Thrombopoietin-mediated phosphorylation of STAT5 (show STAT5A ELISA Kits) triggers its genome-wide relocation to STAT (show STAT1 ELISA Kits) consensus sites, resulting in loss of a uSTAT5 program that restrains megakaryocytic differentiation and activation of STAT5 (show STAT5A ELISA Kits)-driven gene expression.
Furthermore, although the contribution of the TPO treated graft to long-term hematological engraftment was reduced, the TPO treated and untreated grafts both contributed significantly to long-term chimerism in vivo.
TPO treatment also promoted the peripheral induction of Foxp3 (show FOXP3 ELISA Kits)(+) Tregs in conjunction with elevated circulating TGF-beta (show TGFB1 ELISA Kits) levels.
novel findings about aspects of TPO action on stem cells
Mpl (show MPL ELISA Kits) expression, but not Tpo, is fundamental in the development of JAK2V617F(+) myeloproliferative neoplasms
Thrombopoietin/MPL (show MPL ELISA Kits) signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 (show MECOM ELISA Kits) leukemia.
Megakaryocytes regulate cell cycle quiescence of hematopoietic stem cell through the production of thrombopoietin.
IEX-1 (show IER3 ELISA Kits) has a role in activation of Erk (show EPHB2 ELISA Kits) and NF-kB pathways, which affects thrombopoietin-promoted NHEJ DNA repair in hematopoietic stem cells
Findings establish that Clock regulates Thpo and Mpl (show MPL ELISA Kits) expression in vivo, and demonstrate an important link between the body's circadian timing mechanisms and megakaryopoiesis.
Signal transduction pathway of ERK1/2 (show MAPK1/3 ELISA Kits) participates in the activation of thrombopoietin in inflammatory injury of BV2 (show DNAH9 ELISA Kits) cells.
Megakaryocytopoiesis is the cellular development process that leads to platelet production. The protein encoded by this gene is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. This protein is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene. Mutations in this gene are the cause of thrombocythemia 1. Alternate splicing results in multiple transcript variants of this gene.
thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor)
, MPL ligand
, c-mpl ligand
, megakaryocyte colony-stimulating factor
, megakaryocyte growth and development factor
, megakaryocyte stimulating factor
, myeloproliferative leukemia virus oncogene ligand
, thrombopoietin nirs variant 1
, C-mpl ligand